Stagliano; Nancy E.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Stagliano; Nancy E..The latest application filed is for "anti-complement c1s antibodies and uses thereof".
Company Profile
9.32.42
- Stagliano; Nancy E. - South San Francisco CA
- Stagliano; Nancy E. - Santa Barbara CA
- Stagliano; Nancy E. - San Francisco CA
- Stagliano; Nancy E. - Santa Barbraa CA
- Stagliano, Nancy E. - North Reading MA
Patent Activity
| Patent | Date |
|---|---|
| Anti-complement C1s Antibodies And Uses Thereof App 20220204647 - Van Vlasselaer; Peter ; et al. | 2022-06-30 |
| Anti-complement C1s Antibodies And Uses Thereof App 20220185912 - Van Vlasselaer; Peter ; et al. | 2022-06-16 |
| Proproteins And Methods Of Use Thereof App 20200308243 - Stagliano; Nancy E. ; et al. | 2020-10-01 |
| Anti-complement C1s Antibodies And Uses Thereof App 20200079875 - Van Vlasselaer; Peter ; et al. | 2020-03-12 |
| Anti-complement C1s Antibodies And Uses Thereof App 20200079876 - Van Vlasselaer; Peter ; et al. | 2020-03-12 |
| Anti-c1s Antibodies And Methods Of Use Thereof App 20200048332 - Panicker; Sandip ; et al. | 2020-02-13 |
| Cleavage-activatable interferon-alpha proprotein Grant 10,513,549 - Stagliano , et al. Dec | 2019-12-24 |
| Anti-jagged 1/jagged 2 Cross-reactive Antibodies, Activatable Anti-jagged Antibodies And Methods Of Use Thereof App 20190367589 - WEST; James William ; et al. | 2019-12-05 |
| Anti-complement C1s antibodies Grant 10,457,745 - Van Vlasselaer , et al. Oc | 2019-10-29 |
| Anti-complement C1s antibodies Grant 10,450,382 - Van Vlasselaer , et al. Oc | 2019-10-22 |
| Methods of Treating a Tauopathy App 20190169275 - Griswold-Prenner; Irene ; et al. | 2019-06-06 |
| Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof Grant 10,301,380 - West , et al. | 2019-05-28 |
| Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV Grant 10,118,961 - Stagliano , et al. November 6, 2 | 2018-11-06 |
| Methods of treating a tauopathy Grant 10,040,847 - Griswold-Prenner , et al. August 7, 2 | 2018-08-07 |
| Anti-jagged 1/jagged 2 Cross-reactive Antibodies, Activatable Anti-jagged Antibodies And Methods Of Use Thereof App 20170298125 - West; James William ; et al. | 2017-10-19 |
| Methods of treating a tauopathy Grant 9,777,058 - Griswold-Prenner , et al. October 3, 2 | 2017-10-03 |
| Proproteins And Methods Of Use Thereof App 20170240608 - Stagliano; Nancy E. ; et al. | 2017-08-24 |
| Anti-complement C1s Antibodies And Uses Thereof App 20170226230 - Van Vlasselaer; Peter ; et al. | 2017-08-10 |
| Anti-complement C1s Antibodies And Uses Thereof App 20170226229 - Van Vlasselaer; Peter ; et al. | 2017-08-10 |
| Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof Grant 9,688,748 - West , et al. June 27, 2 | 2017-06-27 |
| Methods Of Treating A Tauopathy App 20170174755 - GRISWOLD-PRENNER; Irene ; et al. | 2017-06-22 |
| Soluble notch receptor proproteins and methods of use thereof Grant 9,644,016 - Stagliano , et al. May 9, 2 | 2017-05-09 |
| Modified Antibody Compositions, Methods Of Making And Using Thereof App 20170081397 - Stagliano; Nancy E. ; et al. | 2017-03-23 |
| Methods of treating a tauopathy Grant 9,567,395 - Griswold-Prenner , et al. February 14, 2 | 2017-02-14 |
| Anti-complement C1s antibodies and methods of inhibiting complement C1s activity Grant 9,562,106 - Van Vlasselaer , et al. February 7, 2 | 2017-02-07 |
| Methods of inhibiting complement C4 activation with anti-complement C1s antibodies Grant 9,562,092 - Van Vlasselaer , et al. February 7, 2 | 2017-02-07 |
| Methods Of Treating A Tauopathy App 20160355578 - GRISWOLD-PRENNER; Irene ; et al. | 2016-12-08 |
| Anti-complement C1s antibodies and methods of inhibiting complement C1s activity Grant 9,512,233 - Van Vlasselaer , et al. December 6, 2 | 2016-12-06 |
| Modified antibody compositions, methods of making and using thereof Grant 9,453,078 - Stagliano , et al. September 27, 2 | 2016-09-27 |
| Methods of treating a tauopathy Grant 9,447,180 - Griswold-Prenner , et al. September 20, 2 | 2016-09-20 |
| Anti-Jagged 1/Jagged 2 Cross-Reactive Antibodies, Activatable Anti-Jagged Antibodies And Methods Of Use Thereof App 20160200826 - West; James William ; et al. | 2016-07-14 |
| Anti-complement C1s Antibodies And Uses Thereof App 20160053002 - Van Vlasselaer; Peter ; et al. | 2016-02-25 |
| Methods of inhibiting complement C4 activation with anti-complement C1S antibodies Grant 9,206,259 - Van Vlasselaer , et al. December 8, 2 | 2015-12-08 |
| Anti-complement C1s Antibodies And Uses Thereof App 20150329645 - Van Vlasselaer; Peter ; et al. | 2015-11-19 |
| Anti-complement C1s Antibodies And Uses Thereof App 20150307626 - Van Vlasselaer; Peter ; et al. | 2015-10-29 |
| Anti-complement C1s Antibodies And Uses Thereof App 20150259437 - Van Vlasselaer; Peter ; et al. | 2015-09-17 |
| Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof Grant 9,127,053 - West , et al. September 8, 2 | 2015-09-08 |
| Methods Of Treating A Tauopathy App 20150239963 - Griswold-Prenner; Irene ; et al. | 2015-08-27 |
| Methods Of Treating A Tauopathy App 20150232544 - GRISWOLD-PRENNER; Irene ; et al. | 2015-08-20 |
| Proproteins And Methods Of Use Thereof App 20150203559 - Stagliano; Nancy E. ; et al. | 2015-07-23 |
| Methods of inhibiting activation of complement component C4 with anti-C1s antibodies Grant 9,074,003 - Van Vlasselaer , et al. July 7, 2 | 2015-07-07 |
| Methods of inhibiting activation of complement component C4 with anti-C1s antibodies Grant 9,074,004 - Van Vlasselaer , et al. July 7, 2 | 2015-07-07 |
| Methods of treating a tauopathy Grant 9,051,367 - Griswold-Prenner , et al. June 9, 2 | 2015-06-09 |
| Anti-Complement C1s Antibodies and Uses Thereof App 20150104448 - Van Vlasselaer; Peter ; et al. | 2015-04-16 |
| Proproteins activatable interferon alpha Grant 8,993,266 - Stagliano , et al. March 31, 2 | 2015-03-31 |
| Methods of treating a tauopathy Grant 8,980,271 - Griswold-Prenner , et al. March 17, 2 | 2015-03-17 |
| Methods of treating a tauopathy Grant 8,980,270 - Griswold-Prenner , et al. March 17, 2 | 2015-03-17 |
| Methods Of Treating A Tauopathy App 20150050281 - GRISWOLD-PRENNER; Irene ; et al. | 2015-02-19 |
| Anti-complement C1s antibodies Grant 8,945,562 - Van Vlasselaer , et al. February 3, 2 | 2015-02-03 |
| Methods of treating a tauopathy Grant 8,926,974 - Griswold-Prenner , et al. January 6, 2 | 2015-01-06 |
| Anti-complement C1s Grant 8,877,197 - Van Vlasselaer , et al. November 4, 2 | 2014-11-04 |
| Methods Of Treating A Tauopathy App 20140294831 - GRISWOLD-PRENNER; Irene ; et al. | 2014-10-02 |
| Methods of Treating a Tauopathy App 20140234214 - Griswold-Prenner; Irene ; et al. | 2014-08-21 |
| Anti-complement C1s Antibodies And Uses Thereof App 20140140933 - Van Vlasselaer; Peter ; et al. | 2014-05-22 |
| Anti-Complement C1s Antibodies and Uses Thereof App 20140127208 - Van Vlasselaer; Peter ; et al. | 2014-05-08 |
| Anti-Complement C1s Antibodies and Uses Thereof App 20140127196 - Van Vlasselaer; Peter ; et al. | 2014-05-08 |
| Methods of Treating a Tauopathy App 20140099303 - Griswold-Prenner; Irene ; et al. | 2014-04-10 |
| Methods of Treating a Tauopathy App 20140099304 - Griswold-Prenner; Irene ; et al. | 2014-04-10 |
| Methods of Treating a Tauopathy App 20140086921 - Griswold-Prenner; Irene ; et al. | 2014-03-27 |
| Modified Antibody Compositions, Methods of Making and Using Thereof App 20140024810 - Stagliano; Nancy E. ; et al. | 2014-01-23 |
| Anti-Jagged 1/Jagged 2 Cross-Reactive Antibodies, Activatable Anti-Jagged Antibodies And Methods Of Use Thereof App 20140010810 - West; James William ; et al. | 2014-01-09 |
| Modified Antibody Compositions, Methods of Making and Using Thereof App 20130309230 - Stagliano; Nancy E. ; et al. | 2013-11-21 |
| Modified antibody compositions, methods of making and using thereof Grant 8,563,269 - Stagliano , et al. October 22, 2 | 2013-10-22 |
| Modified antibody compositions, methods of making and using thereof Grant 8,513,390 - Stagliano , et al. August 20, 2 | 2013-08-20 |
| Proproteins and Methods of Use Thereof App 20130101555 - Stagliano; Nancy E. ; et al. | 2013-04-25 |
| Protease activatable interferon alpha proprotein Grant 8,399,219 - Stagliano , et al. March 19, 2 | 2013-03-19 |
| Modified Antibody Compositions, Methods of Making and Using Thereof App 20120207756 - Stagliano; Nancy E. ; et al. | 2012-08-16 |
| Modified Antibody Compositions, Methods of Making and Using Thereof App 20120149061 - STAGLIANO; NANCY E. ; et al. | 2012-06-14 |
| Proproteins And Methods Of Use Thereof App 20100221212 - Stagliano; Nancy E. ; et al. | 2010-09-02 |
| Modified Antibody Compositions, Methods Of Making And Using Thereof App 20100189651 - Stagliano; Nancy E. ; et al. | 2010-07-29 |
| Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44 App 20050037946 - Stagliano, Nancy E. ; et al. | 2005-02-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 